Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -0.36EBITDA per Share
VS
Market
Sector
Industry
History
$ 0.33Close
$ 0.21 - $ 14.01 52-Week Range
Ticker Information
Ticker
ASBPCompany Name
ASPIRE BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQASPIRE BIOPHARMA HOLDINGS INC - EBITDA per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ASBP - EBITDAPS Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -17.99M | $ -0.36 | 1 | 49.33M |
| 3/31/2025 | $ -17.14M | $ -0.45 | 1 | 37.89M |
| 12/31/2024 | $ -1.21M | $ -0.02 | 1 | 50.74M |
| 9/30/2024 | $ -3.57M | $ -0.46 | 1 | 7.77M |
| 6/30/2024 | $ -3.1M | $ -0.37 | 1 | 8.47M |
| 3/31/2024 | $ -683.18K | $ -0.08 | 1 | 8.99M |
| 12/31/2023 | $ 4.47M | $ 0.23 | 1 | 19.18M |
| 9/30/2023 | $ 6.85M | $ 0.76 | 1 | 8.99M |
| 6/30/2023 | $ 7.99M | $ 0.41 | 1 | 19.63M |
| 3/31/2023 | $ 6.3M | $ 0.18 | 1 | 35.94M |
Key Performance Insights, Last 5 Years
- ASPIRE BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -0.
- Over the past 5 years, ASPIRE BIOPHARMA HOLDINGS INC's average EBITDAPS has been $ -0.01.
- The median EBITDAPS for ASPIRE BIOPHARMA HOLDINGS INC during this period was $ -0.01
- ASPIRE BIOPHARMA HOLDINGS INC reached its highest EBITDAPS over the past 5 years at $ 0.76.
- The lowest EBITDAPS recorded by ASPIRE BIOPHARMA HOLDINGS INC in the same timeframe $ -0.46
Similar metrics to Shares WA:
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBITDA per Share
[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for ASPIRE BIOPHARMA HOLDINGS INC is calculated as follows: EBITDA [ $ -25.48K ] / (Shares WA [ 6.25M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -0 ] ASBP - EBITDA per Share, Last 5 years
$ -0.46
Minimum
Sep 30, 2024
$ 0.76
Maximum
Sep 30, 2023
$ -0.01
Average
$ -0.01
Median
EBITDAPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
| filtered constituents | 3.78K |
|---|---|
| min | $ -11.29 |
| max | $ 14.03 |
| average | $ 2.03 |
| median | $ 1 |
| std | $ 4.28 |